Bill Falstich is Vice President of Pfizer’s Primary Care Category Global Supply Chain. His team of 50 colleagues manages supply for some of the world’s largest vaccines, a broad Internal Medicines portfolio, and Pfizer’s Paxlovid antiviral. His team also plays a critical role in the commercialization and market expansion of new products, with many launches planned in the coming years. Bill’s team drives continuous improvement across Pfizer’s Primary Care supply in support of Pfizer’s purpose – delivering breakthroughs that change patients’ lives. This includes aspects of supply chain management such as product strategy and orchestration, product launch management, supply network design and supply issue resolution. Bill began his career with Pfizer in 2001, and since that time has held a number of positions within supply chain management, intercompany operations, logistics and distribution, procurement and business technology. He is a graduate of Penn State University with a BS in Supply Chain and Information Management and earned his MBA from Virginia Commonwealth University. He resides near Collegeville, Pennsylvania with his wife and two sons.
Protecting public health from biothreats to pandemics.
10:10 – 10:50 Coupled lightening talks: ~10 minutes each
How our governments are incentivizing (portfolio approach), especially with biotech and industry?
10:55 – 11:50 Panel: Collaboration with industry: the solution for a sustainable posture for biodefence and global health security
11:50 – 12:50 Panel: Rapid vaccine development through manufacturing innovation
1:00 - 2:00 break
2:00 – 3:10 Panel: What are the remaining bottlenecks holding us back from achieving the 100 day mission?
3:10 – 4:10 Panel: International pandemic funding – how can we make it accessible globally?
4:10 – 5:00 Recap Panel: What are the drivers between different international governments and how can we harmonize these to strengthen our defense from global biothreats?